The GRI has in recent years been introducing ongoing enhancements in its procedures and processes regarding the detection of banned substances and misuse of medication within the sport.  In 2019, the National Greyhound Laboratory in Limerick analysed 5,702 samples from greyhounds which returned 15 adverse analytical findings (0.3% of the overall total). 

All adverse analytical findings identified are processed by the independent Control Committee and where appropriate the Control Appeal Committee.  The arrangements regarding the Committees and the level of fines and penalties will be further enhanced when the Greyhound Racing Act of 2019 is commenced.  The GRI expects that the Act will commence in the current year. 

As part of its review of overall sampling and testing arrangements, the Board has agreed an expansion of the testing regime to include blood and/or hair testing as added measures in the overall sampling and testing programme. 

Urine sampling will continue to be the main method of sampling as it is accepted worldwide that urine is the more effective matrix for analysis for prohibited substances.  It is, however, the objective of GRI to maintain the options available in its anti-doping programme, to increase the number of out of competition samples and to target sampling where intelligence indicates the possible use of “banned substances”.  In this regard, blood sampling and hair testing will be undertaken on a random and targeted basis and will be a supplement and added measure to urine sampling.

The above arrangements will be brought into immediate effect.